Retina in 2020 and Beyond

October 13, 2020

Sponsored Content

These podcasts are an editorially independent initiative with support by Roche. To learn more about Roche Ophthalmology, visit

Presented by:

Anat Loewenstein, MD
Prof. dr. Marc D. de Smet, MDCM, PhD, FRCSC, FRCOphth, DABO, FMH

Anat Loewenstein, MD, Professor of Ophthalmology, Vice Dean of the Faculty of Medicine, and Sidney Fox Chair of Ophthalmology at the Sackler Faculty of Medicine at the Tel Aviv University. Dr. Loewenstein is involved in the development of multiple innovative efforts, including the development of novel technology for the early detection of macular degeneration, the development of automated technology for detection of retinal disease activity, and the development of augmented virtual reality to replace the operating microscope. She serves as the Editor of the Journal Case Reports in Ophthalmology, and has published more than 350 papers as well as multiple ophthalmic textbook chapters.

Prof. dr. Marc D. de Smet, MDCM, PhD, FRCSC, FRCOphth, DABO, FMH, is the Founder and head of MicroInvasive Ocular Surgery Center (MIOS) sa, Lausanne, Switzerland, and CMO – Preceyes bv, an ophthalmic robotics company. He has authored or co-authored more than 160 articles in peer reviewed international journals, 30 chapters or book chapters, and more than 50 non-peer reviewed articles. He has given more than 500 invited lectures at meetings or named lectures.He also discovered new treatments such as the use of methotrexate for the treatment of ocular lymphoma or ocriplasmin in vitreomacular traction.

Presented by:

Ramin Tadayoni, MD, PhD
Robert E. MacLaren FMedSci FRCOphth FRCS FACS VR

Join Ophthalmology Times Europe, Dr. Ramin Tadayoni ,and Dr. Robert MacLaren as these two experts discuss surgical innovations in the retina, from incremental improvements in instrumentation and visualization to what the future might hold with better imaging and robotics.

Robert E. MacLaren FMedSci FRCOphth FRCS FACS VR a practising Consultant Ophthalmologist at the Oxford Eye Hospital. He specialised first as a junior doctor in Oxford and then moved to Moorfields Eye Hospital in London, where he was a Consultant Vitreoretinal Surgeon and led research into retinal diseases. He is Professor of Ophthalmology at the University of Oxford and Honorary Professor of Ophthalmology at the UCL Institute of Ophthalmology. He has led pioneering work in the treatment of blindness caused by retinal diseases.

Ramin Tadayoni, MD, PhD, is Professor of Ophthalmology at University of Paris and Head of the department of Ophthalmology at the University of Paris, and Department Chairman at Lariboisière, Saint Louis University Hospitals and Rothschild Foundation Hospital Paris (France). He is also the leader of French government funded RHU EviRed research on artificial intelligence for diabetic retinopathy. He is a EURETINA board member, past President of the French-speaking Retina Specialists Club, and since 2017 elected as member of the French Académie Nationale de Chirurgie. He is a pioneer in the diagnosis and treatment of retinal diseases, retinovitreal surgery and ophthalmic imaging.